APA
ZSAN

American Portfolios Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

American Portfolios Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6
Closed -$102 – 3337
2020
Q4 		$102 Hold
6
– – ﹤0.01% 2952
2020
Q3 		$314 Buy
+6
New +$279 ﹤0.01% 2876
2019
Q1 		– Sell
-2
Closed -$148 – 2668
2018
Q4 		$148 Buy
+2
New +$253 ﹤0.01% 2360

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WG
Winton Group London, United Kingdom $3.09B AUM 40.4% 1-Year Est. Return

American Portfolios Advisors's ZSAN Position: Q1 2021 in Review

American Portfolios Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q1 2021, closing a stake of 6 shares — an estimated $102 sold.

American Portfolios Advisors first reported a position in ZSAN in Q4 2018 and held it in 3 quarters. The position peaked at $314 in Q3 2020. 35 funds tracked by Wall St. Rank hold ZSAN as of Q1 2021.

  • American Portfolios Advisors reported no remaining Zosano Pharma Corporation position as of Q1 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 6 Zosano Pharma Corporation shares in Q1 2021, an estimated $102.
  • American Portfolios Advisors first reported a position in Zosano Pharma Corporation in Q4 2018 and held it in 3 quarters.
  • American Portfolios Advisors's Zosano Pharma Corporation position peaked at $314 in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2021.

Based on American Portfolios Advisors's 13F filing for Q1 2021, filed 22 Mar 2023.